A citation-based method for searching scientific literature

Ziqiang Li, Yemei Song, Yeyang Xu, Yue Shen, Nasha Zhang, Ming Yang, Dianke Yu. J Cancer 2020
Times Cited: 2







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Oncogene HSPH1 modulated by the rs2280059 genetic variant diminishes EGFR-TKIs efficiency in advanced lung adenocarcinoma.
Yankang Li, Nasha Zhang, Li Zhang, Yemei Song, Jie Liu, Jinming Yu, Ming Yang. Carcinogenesis 2020
6
100

GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.
Shengping Li, Ji Qian, Yuan Yang, Wanting Zhao, Juncheng Dai, Jin-Xin Bei, Jia Nee Foo, Paul J McLaren, Zhiqiang Li, Jingmin Yang,[...]. PLoS Genet 2012
141
100


Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.
J Ferlay, M Colombet, I Soerjomataram, C Mathers, D M Parkin, M Piñeros, A Znaor, F Bray. Int J Cancer 2019
100

Hepatocellular carcinoma.
Josep M Llovet, Jessica Zucman-Rossi, Eli Pikarsky, Bruno Sangro, Myron Schwartz, Morris Sherman, Gregory Gores. Nat Rev Dis Primers 2016
100

Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers.
Daiki Miki, Hidenori Ochi, C Nelson Hayes, Hiromi Abe, Tadahiko Yoshima, Hiroshi Aikata, Kenji Ikeda, Hiromitsu Kumada, Joji Toyota, Takashi Morizono,[...]. Nat Genet 2011
117
100

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.
Josep M Llovet, Maria Isabel Real, Xavier Montaña, Ramon Planas, Susana Coll, John Aponte, Carmen Ayuso, Margarita Sala, Jordi Muchart, Ricard Solà,[...]. Lancet 2002
100

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
Chung-Mau Lo, Henry Ngan, Wai-Kuen Tso, Chi-Leung Liu, Chi-Ming Lam, Ronnie Tung-Ping Poon, Sheung-Tat Fan, John Wong. Hepatology 2002
100

Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers.
Hongxing Zhang, Yun Zhai, Zhibin Hu, Chen Wu, Ji Qian, Weihua Jia, Fuchao Ma, Wenfeng Huang, Lixia Yu, Wei Yue,[...]. Nat Genet 2010
259
100

Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.
Vinod Kumar, Naoya Kato, Yuji Urabe, Atsushi Takahashi, Ryosuke Muroyama, Naoya Hosono, Motoyuki Otsuka, Ryosuke Tateishi, Masao Omata, Hidewaki Nakagawa,[...]. Nat Genet 2011
262
100


MED13L integrates Mediator-regulated epigenetic control into lung cancer radiosensitivity.
Nasha Zhang, Yemei Song, Yeyang Xu, Jiandong Liu, Yue Shen, Liqing Zhou, Jinming Yu, Ming Yang. Theranostics 2020
7
50

Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial.
Lai Wei, Tingting Zhao, Ji Zhang, Qing Mao, Guozhong Gong, Yongtao Sun, Yongping Chen, Maorong Wang, Deming Tan, Zuojiong Gong,[...]. Hepatology 2022
2
50

Role of long non-coding RNA H19 in therapy resistance of digestive system cancers.
Jingting Wang, Xiao Ma, Hai Si, Zhongjun Ma, Yan Ma, Jing Wang, Bangwei Cao. Mol Med 2021
2
50

Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk.
Xinyu Yang, Dianke Yu, Yanli Ren, Jinyu Wei, Wenting Pan, Changchun Zhou, Liqing Zhou, Yu Liu, Ming Yang. Am J Hum Genet 2016
19
50

Long Noncoding RNA H19: A Key Player in Liver Diseases.
Yanyan Wang, Phillip B Hylemon, Huiping Zhou. Hepatology 2021
4
50

Silencing of lncRNA PVT1 by miR-214 inhibits the oncogenic GDF15 signaling and suppresses hepatocarcinogenesis.
Xiangyu Xiong, Jupeng Yuan, Nasha Zhang, Yan Zheng, Jibing Liu, Ming Yang. Biochem Biophys Res Commun 2020
10
50

LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363.
Hai Huang, Jie Chen, Cheng-Ming Ding, Xin Jin, Ze-Ming Jia, Jian Peng. J Cell Mol Med 2018
82
50

Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling.
Yuki Katayama, Moegi Maeda, Ken Miyaguchi, Shota Nemoto, Mahmut Yasen, Shinji Tanaka, Hiroshi Mizushima, Yutaka Fukuoka, Shigeki Arii, Hiroshi Tanaka. Oncol Lett 2012
46
50

The Good, the Bad, the Question-H19 in Hepatocellular Carcinoma.
Lysann Tietze, Sonja M Kessler. Cancers (Basel) 2020
11
50

The long noncoding RNA GAS8-AS1 suppresses hepatocarcinogenesis by epigenetically activating the tumor suppressor GAS8.
Wenting Pan, Nasha Zhang, Wenjuan Liu, Jibing Liu, Liqing Zhou, Yang Liu, Ming Yang. J Biol Chem 2018
31
50


Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma.
Edie-Rosmin Wu, Ying-Erh Chou, Yu-Fan Liu, Kuan-Chun Hsueh, Hsiang-Lin Lee, Shun-Fa Yang, Shih-Chi Su. Genes (Basel) 2019
19
50

Long non‑coding RNA H19 is involved in sorafenib resistance in hepatocellular carcinoma by upregulating miR‑675.
Yongzi Xu, Yanhui Liu, Zhenrong Li, Hao Li, Xiqing Li, Lei Yan, Jiayan Mao, Jian Shen, Wei Chen, Fei Xue. Oncol Rep 2020
21
50

Thalamic haemorrhage due to tuberculous arteritis.
N Kumar, W Singh. J Assoc Physicians India 1991
1
100

Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population.
Chao Yang, Ran Tang, Xiang Ma, Younan Wang, Dakui Luo, Zekuan Xu, Yi Zhu, Li Yang. Oncotarget 2015
102
50

Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.
Ádám Nagy, András Lánczky, Otília Menyhárt, Balázs Győrffy. Sci Rep 2018
685
50

LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
H Xiong, Z Ni, J He, S Jiang, X Li, J He, W Gong, L Zheng, S Chen, B Li,[...]. Oncogene 2017
221
50

Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.
Lucia A Hindorff, Praveen Sethupathy, Heather A Junkins, Erin M Ramos, Jayashri P Mehta, Francis S Collins, Teri A Manolio. Proc Natl Acad Sci U S A 2009
50


N6-methyladenosine reader YTHDC2 and eraser FTO may determine hepatocellular carcinoma prognoses after transarterial chemoembolization.
Jiandong Liu, Dongyang Wang, Jianyuan Zhou, Leirong Wang, Nasha Zhang, Liqing Zhou, Jiajia Zeng, Jibing Liu, Ming Yang. Arch Toxicol 2021
3
50

Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets.
Zhihong Zhu, Futao Zhang, Han Hu, Andrew Bakshi, Matthew R Robinson, Joseph E Powell, Grant W Montgomery, Michael E Goddard, Naomi R Wray, Peter M Visscher,[...]. Nat Genet 2016
689
50

Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Carlo Schneider, Andreas Teufel, Tetyana Yevsa, Frank Staib, Anja Hohmeyer, Gudrun Walenda, Henning W Zimmermann, Mihael Vucur, Sebastian Huss, Nikolaus Gassler,[...]. Gut 2012
114
50

Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
Peng Yuan, Shen Wang, Feng Zhou, Shaogui Wan, Yefa Yang, Xiaojun Huang, Zhaohui Zhang, Yong Zhu, Hongxin Zhang, Jinliang Xing. Cancer Sci 2014
21
50

Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.
Ligia Craciun, Roland de Wind, Pieter Demetter, Valerio Lucidi, Ali Bohlok, Sébastien Michiels, Fikri Bouazza, Michael Vouche, Ilario Tancredi, Gontran Verset,[...]. BMC Cancer 2020
9
50

Mapping cis- and trans-regulatory effects across multiple tissues in twins.
Elin Grundberg, Kerrin S Small, Åsa K Hedman, Alexandra C Nica, Alfonso Buil, Sarah Keildson, Jordana T Bell, Tsun-Po Yang, Eshwar Meduri, Amy Barrett,[...]. Nat Genet 2012
518
50

Genetic variants in the EPCAM gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma with portal vein tumor thrombus.
Xiaohe Yu, Naijian Ge, Xu Guo, Shuqun Shen, Jun Liang, Xiaojun Huang, Shaogui Wan, Jingliang Xing, Qichao Huang, Yefa Yang. PLoS One 2014
7
50

PancanQTL: systematic identification of cis-eQTLs and trans-eQTLs in 33 cancer types.
Jing Gong, Shufang Mei, Chunjie Liu, Yu Xiang, Youqiong Ye, Zhao Zhang, Jing Feng, Renyan Liu, Lixia Diao, An-Yuan Guo,[...]. Nucleic Acids Res 2018
84
50

Polymorphisms of HLA-DQB1 predict survival of hepatitis B virus-related hepatocellular carcinoma patients receiving hepatic resection.
Xiaoguang Liu, Long Yu, Chuangye Han, Sichong Lu, Guangzhi Zhu, Hao Su, Wei Qin, Xiwen Liao, Tao Peng. Clin Res Hepatol Gastroenterol 2016
8
50

Systematic identification of trans eQTLs as putative drivers of known disease associations.
Harm-Jan Westra, Marjolein J Peters, Tõnu Esko, Hanieh Yaghootkar, Claudia Schurmann, Johannes Kettunen, Mark W Christiansen, Benjamin P Fairfax, Katharina Schramm, Joseph E Powell,[...]. Nat Genet 2013
50

Recombination centres and the orchestration of V(D)J recombination.
David G Schatz, Yanhong Ji. Nat Rev Immunol 2011
319
50

A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
Binyu Zhao, Jianguo Lu, Jikai Yin, Hanqiang Liu, Xu Guo, Yefa Yang, Naijian Ge, Yong Zhu, Hongxin Zhang, Jinliang Xing. Liver Int 2012
34
50


Polymorphisms in genes of the de novo lipogenesis pathway and overall survival of hepatocellular carcinoma patients undergoing transarterial chemoembolization.
You-Sheng Wu, Deng-Ke Bao, Jing-Yao Dai, Cheng Chen, Hong-Xin Zhang, YeFa Yang, Jin-Liang Xing, Xiao-Jun Huang, Shao-Gui Wan. Asian Pac J Cancer Prev 2015
4
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.